丙泊酚复合地佐辛靶控输注在妇科腔镜手术全身麻醉中应用效果观察.docVIP

丙泊酚复合地佐辛靶控输注在妇科腔镜手术全身麻醉中应用效果观察.doc

此“医疗卫生”领域文档为创作者个人分享资料,不作为权威性指导和指引,仅供参考
  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
丙泊酚复合地佐辛靶控输注在妇科腔镜手术全身麻醉中应用效果观察

丙泊酚复合地佐辛靶控输注在妇科腔镜手术全身麻醉中的应用效果观察   [摘要] 目的 探究丙泊酚复合地佐辛靶控输注在妇科腔镜手术全身麻醉中的应用效果。 方法 选取我院2014年11月~2015年11月收治的行妇科腔镜手术全身麻醉患者共91例,随机分为对照组与观察组,对照组接受丙泊酚复合瑞芬太尼靶控输注,观察组接受丙泊酚复合地佐辛靶控输注。比较两组患者不同时间点血流动力学指标、麻醉效果及不良反应发生率。 结果 两组患者T0时MAP、HR、SaO2%及RR差异无统计学意义(P0.05)。观察组T1、T2、T3及T4时ΔMAP、ΔHR、ΔSaO2%及ΔRR均明显低于对照组(P0.05)。观察组丙泊酚使用量为(413.1±18.4)mg、VAS评分为(3.15±0.35),不良反应发生率为4.3%,均明显低于对照组(P0.05)。 结论 丙泊酚复合地佐辛靶控输注可有效稳定术中循环,减少丙泊酚使用量及降低不良反应发生率,镇痛效果好,值得临床推广应用。   [关键词] 丙泊酚;地佐辛;靶控输注;全身麻醉;妇科腔镜手术   [中图分类号] R971+.2 [文献标识码] A [文章编号] 1674-4721(2016)04(b)-0116-03   [Abstract] Objective To explore the application effects of propofol combined with target-controlled infusion dezocine in gynecological laparoscopic surgery with general anesthesia. Methods 91 cases gynecological laparoscopic surgery with general anesthesia patients from November 2014 to November 2015 in our hospital were selected and were randomly divided into control group and observation group.Patients in control group were given propofol combined with target-controlled infusion remifentanil.Patients in observation group were given propofol combined with target-controlled infusion dezocine.The hemodynamic index,anesthesia effects and the incidence rate of adverse effects at different times between two groups were compared. Results The MAP,HR,SaO2% and RR at T0 between two groups had no obvious difference (P0.05).The ΔMAP,ΔHR,ΔSaO2% and ΔRR in observation group at T1,T2,T3 and T4 were obvious lower than those in control group (P0.05).The propofol usage amount,VAS score and incidence rate of adverse effects in observation group was respectively (413.1±18.4)mg,(3.15±0.35) and 4.3%,which was obvious lower than that in control group (P0.05). Conclusion Propofol combined with target-controlled infusion dezocine can maintain the circulation stable effectively,decrease the usage amount of propofol, has less incidence rate of adverse effects and good analgesic effect.It is worth to popularize in clinic.   [Key words] Propofol;Dezocine;Target-controlled

文档评论(0)

bokegood + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档